Ghrelin has been investigated for its role in angiogenesis and improved recovery from ischemia as a potential treatment for PAD [23], but the role of GHSR-1a in inflammation, a major risk factor for PAD progression, has not yet been established. Here, GHSR is linked to peripheral arterial disease.